Nanopore Protein Sequencing Achieves Significant New Milestones
Clinical Chemistry · 2024
DOI: 10.1093/clinchem/hvae041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Chemistry, 2024. Verfasst von Brian C Searle. Beteiligte Einrichtung: Department of Biomedical Informatics, The Ohio State University Medical Center, Columbus, OH, United States. Hauptthemen laut MEDLINE: Nanopore Sequencing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIH HHS, NIH.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Informatics, The Ohio State University Medical Center, Columbus, OH, United States.
- Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States.
- Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, United States.
ORCID-Profile: Brian C Searle
Förderung
- NIGMS NIH HHS
- NIH HHS
- NIH
Zitieren
APA
Searle, B. C. (2024). Nanopore Protein Sequencing Achieves Significant New Milestones. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvae041
Vancouver
Searle BC. Nanopore Protein Sequencing Achieves Significant New Milestones. Clinical Chemistry. 2024. doi:10.1093/clinchem/hvae041
BibTeX
@article{Searle2024,
author = {Searle, Brian C},
title = {Nanopore Protein Sequencing Achieves Significant New Milestones},
journal = {Clinical Chemistry},
year = {2024},
doi = {10.1093/clinchem/hvae041}
}
EUVIMED